Anúncio
Anúncio

SGRY

SGRY logo

Surgery Partners, Inc. Common Stock

15.91
USD
Patrocinado
+0.20
+1.30%
09 de jan., 14:49 UTC -5
Abrir

Relatórios de Lucros SGRY

Rácio de surpresa positiva

SGRY separação 18 de 40 últimas estimativas.

45%

Próximo Relatório

Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$883.74M
/
$0.32
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+7.58%
/
+146.15%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+2.24%
/
-27.27%

Surgery Partners, Inc. Common Stock earnings per share and revenue

On 10 de nov. de 2025, SGRY reported earnings of 0.13 USD per share (EPS) for Q3 25, missing the estimate of 0.16 USD, resulting in a -23.03% surprise. Revenue reached 821.50 milhão, compared to an expected 837.45 milhão, with a -1.90% difference. The market reacted with a -25.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of 0.32 USD, with revenue projected to reach 883.74 milhão USD, implying an aumentar of 146.15% EPS, and aumentar of 7.58% in Revenue from the last quarter.
FAQ
For Q3 2025, Surgery Partners, Inc. Common Stock reported EPS of $0.13, missing estimates by -23.03%, and revenue of $821.50M, -1.9% below expectations.
The stock price moved down -25.42%, changed from $21.50 before the earnings release to $16.04 the day after.
The next earning report is scheduled for 02 de mar. de 2026.
Based on 14 analistas, Surgery Partners, Inc. Common Stock is expected to report EPS of $0.32 and revenue of $883.74M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio